1. Home
  2. ARVN vs QSG Comparison

ARVN vs QSG Comparison

Compare ARVN & QSG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARVN
  • QSG
  • Stock Information
  • Founded
  • ARVN 2015
  • QSG 2019
  • Country
  • ARVN United States
  • QSG China
  • Employees
  • ARVN N/A
  • QSG N/A
  • Industry
  • ARVN Biotechnology: Pharmaceutical Preparations
  • QSG Other Consumer Services
  • Sector
  • ARVN Health Care
  • QSG Real Estate
  • Exchange
  • ARVN Nasdaq
  • QSG Nasdaq
  • Market Cap
  • ARVN 456.2M
  • QSG 441.6M
  • IPO Year
  • ARVN 2018
  • QSG 2023
  • Fundamental
  • Price
  • ARVN $7.61
  • QSG $9.94
  • Analyst Decision
  • ARVN Buy
  • QSG Buy
  • Analyst Count
  • ARVN 22
  • QSG 2
  • Target Price
  • ARVN $20.02
  • QSG $5.81
  • AVG Volume (30 Days)
  • ARVN 1.3M
  • QSG 924.8K
  • Earning Date
  • ARVN 10-29-2025
  • QSG 09-17-2025
  • Dividend Yield
  • ARVN N/A
  • QSG 1.86%
  • EPS Growth
  • ARVN N/A
  • QSG 92.28
  • EPS
  • ARVN N/A
  • QSG 1.12
  • Revenue
  • ARVN $372,800,000.00
  • QSG $428,283,608.00
  • Revenue This Year
  • ARVN $1.61
  • QSG N/A
  • Revenue Next Year
  • ARVN N/A
  • QSG N/A
  • P/E Ratio
  • ARVN N/A
  • QSG $9.05
  • Revenue Growth
  • ARVN 299.57
  • QSG N/A
  • 52 Week Low
  • ARVN $5.90
  • QSG $1.60
  • 52 Week High
  • ARVN $29.61
  • QSG $15.64
  • Technical
  • Relative Strength Index (RSI)
  • ARVN 49.90
  • QSG 56.73
  • Support Level
  • ARVN $7.58
  • QSG $8.36
  • Resistance Level
  • ARVN $7.89
  • QSG $13.63
  • Average True Range (ATR)
  • ARVN 0.37
  • QSG 1.05
  • MACD
  • ARVN -0.03
  • QSG 0.24
  • Stochastic Oscillator
  • ARVN 18.42
  • QSG 39.11

About ARVN Arvinas Inc.

Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.

About QSG QuantaSing Group Limited

QuantaSing Group Ltd is a lifestyle solution provider. The company offers engaging, affordable, and accessible online and offline services, as well as consumer products in selected areas that address adult learners. The group has expanded into the pop toys sector and continues to strategically diversify its portfolio by capturing opportunities in consumer sectors while maintaining financial discipline.

Share on Social Networks: